Emmessar Biotech & Nutrition has informed that, pursuant to Regulation 29 (1) (a) of Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on Thursday the February 06, 2025, at Mumbai, to consider and approve unaudited Financial Results of the Company for the quarter ended December 31, 2024. Further, pursuant SEBI (Prohibition of Insider Trading), Regulations, 2015, as amended from time to time the Trading Window, as informed to the exchange vide letter dated 24.12.2024 in respect of trading in equity shares of the Company will remain closed up to February 08, 2025.
The above information is a part of company’s filings submitted to BSE.
